Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell membrane and metabolic enzymes represent a composite target profile addressed by broad-spectrum antimicrobial agents, including antiseptics, preservatives, and heavy metal ions (Lansdown, 2006). The cell membrane is a critical structure for maintaining osmotic pressure, nutrient transport, and energy transduction via the electron transport chain, while metabolic enzymes are essential for the synthesis of nucleic acids, proteins, and cell wall components (NIH PMC6264685). Agents targeting this dual system, such as silver ions and certain organic acids like potassium sorbate, typically disrupt the physical integrity of the membrane while simultaneously inactivating intracellular enzymes (ChemPoint, 2024). This multi-pronged attack leads to rapid loss of cellular homeostasis and eventual cell death, making it a potent strategy for disinfection and preservation. In clinical practice, silver sulfadiazine is a prominent example, used topically to prevent infections in burn wounds by hitting these targets (StatPearls, 2023). Potassium sorbate is another example, widely used in the food and cosmetic industries to inhibit the growth of molds and yeasts by disrupting these same components (EFSA, 2022). While effective, the broad-spectrum nature of these targets can pose challenges regarding selectivity and potential toxicity to human tissues, necessitating careful formulation. Monitoring efficacy typically involves measuring the reduction in microbial load or determining the minimum inhibitory concentration (MIC). Understanding the interaction between drugs and these fundamental microbial components is crucial for developing effective antimicrobial strategies and managing resistance.
Simultaneous disruption of the microbial lipid bilayer and inhibition of essential intracellular enzymes through binding or denaturation (Lansdown, 2006; ChemPoint, 2024).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and metabolic enzymes.